Ichor (ICHR) Q4 2025 earnings review
Trough Confirmed, Recovery Guided
Ichor navigated a guided dip in Q4, delivering revenue of $223.6M (beating the $220M midpoint) and marking the bottom of the current cycle. While profitability remains razor-thin with Non-GAAP EPS of just $0.01 and margins compressing to 11.7%, the narrative has shifted to recovery. Management's Q1 FY26 guidance projects an immediate revenue bounce to ~$250M and an EPS jump to $0.12, signaling that the worst of the inventory and demand digestion is likely over.
🐂 Bull Case
Guidance for Q1 2026 indicates an immediate 11.8% sequential revenue jump to $250M (midpoint). CEO Phil Barros cited 'solidly upward momentum' and 'strengthening demand,' suggesting the semiconductor equipment down-cycle has officially turned.
Despite a challenging environment, Ichor grew FY25 revenue 11.6% YoY to $947.7M, outperforming the broader Wafer Fab Equipment (WFE) market which was largely flat or down for many peers.
🐻 Bear Case
Non-GAAP gross margin deteriorated for the third consecutive quarter, falling to 11.7% in Q4 from 12.5% in Q2. This is far below the company's historical 'mid-teens' targets, indicating that volume recovery hasn't yet fixed operational inefficiencies.
The company posted a substantial GAAP net loss of $52.8M for FY25 and $16.0M for Q4 alone. Heavy adjustments (restructuring, inventory impairment) continue to cloud the true earnings power.
⚖️ Verdict: ⚪
Neutral/Positive. The revenue guidance is the 'all-clear' signal investors were waiting for, but the execution on margins remains sloppy. The stock is a play on the 2026 semi-cycle recovery, but Ichor must prove it can translate higher sales into actual profit margins.
Key Themes
Gross Margin Erosion
Margins are moving in the wrong direction. Non-GAAP Gross Margin slipped to 11.7% in Q4, down from 12.1% in Q3 and 12.5% in Q2. Management promises 'meaningfully improved' performance in FY26, but the data currently shows a company struggling to convert sales into profit efficiently, likely due to under-absorption and product mix issues.
Demand Resurgence
The Q1 2026 outlook is decidedly bullish. Management notes 'early indications of customer demand' supporting a view that the upward trend will continue into the second half of the year. This validates the thesis that Q4 was indeed the trough.
Cleaning Up the Balance Sheet
Ichor took significant hits to clean up its books, recording $3.1M in inventory impairments in Q4 and nearly $20M for the full year. While painful (driving GAAP losses), these 'kitchen sink' quarters often precede a turnaround in profitability as old inventory drags are removed.
Cash Flow vs Earnings Disconnect
For FY25, Ichor reported a GAAP Net Loss of $52.8M but positive Operating Cash Flow of $29.9M. This divergence is driven by massive non-cash charges ($33.5M depreciation, $19.8M inventory impairment). While positive cash flow is good, the quality of earnings is low until GAAP results converge with cash generation.
Operational Leverage Lag
Despite FY25 revenue growing 11.6% YoY, Non-GAAP Operating Margin was flat at 2.2% (same as FY24). The company has failed to demonstrate operating leverage on rising sales over the last year, raising questions about its cost structure.
Other KPIs
Narrowly avoided a loss. While better than the GAAP loss of $(0.46), this is a significant drop from $0.07 in Q3 and $0.12 in Q1. Profitability bottomed out alongside revenue.
Stable. Generated $9.2M in operating cash flow against $3.2M in CapEx. The company continues to self-fund despite P&L losses, ending the quarter with $98.3M in cash, up $5.8M sequentially.
Improving. Inventory decreased by $9.9M sequentially (down ~4%). This reduction is critical for working capital efficiency and suggests the 'destocking' phase is largely complete.
Guidance
Accelerating. The midpoint of $250M implies an 11.8% sequential increase from Q4. This signals the start of the recovery phase.
Accelerating. The midpoint of $0.12 is a 12x increase from the $0.01 reported in Q4. This implies that the incremental revenue is finally starting to flow through to the bottom line.
Improving. Midpoint is still slightly negative $(-0.04), but significantly better than the $(0.46) GAAP loss in Q4. The company is inching closer to real GAAP profitability.
Key Questions
Gross Margin Bridge
Gross margins dipped to 11.7% in Q4 despite revenue beating the midpoint. What specific inefficiencies caused this compression, and what gives management confidence in 'meaningfully improved' margins for FY26?
Strategic Initiatives Specifics
The release mentions 'new strategic initiatives' reflecting operational priorities. Are these cost cuts, manufacturing shifts, or product mix changes, and what are the associated upfront costs?
Customer Concentration Risks
Given previous quarters' volatility with customers #3 and #4, has the demand recovery in Q1 been broad-based across all major customers, or is it concentrated in a specific account?